Apparatus and method for treating an ocular disorder
CA 2951478 A1 · Owner: Glaukos Corporation · Inventors: Gharib, Morteza; Bergheim, Olav B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An implant for treating an ocular disorder comprises an inlet portion configured to extend , through a portion of a trabecular meshwork of an eye and an outlet portion , configured to extend into Schlemm's canal of said eye. The outlet portion has at least one protrusion configured to exert , traction against an inner surface of Schlemm's canal the protrusion extending , from the implant in a direction substantially perpendicular to a long axis of Schlemm's canal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 8, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 8, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 8, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.